Solvemed Company
Revolutionising neurology diagnostics and drug discovery with the power of Artificial Intelligence.
Total Funding:
4403981.0
Last Funding Type:
Seed
Investors Number:
7.0
Estimated Revenue:
Less than $1M
Founded Date:
2019-09-01
Industry:
Neurodegenerative disease diagnosis and treatment
Last Funding Date:
2022-10-05
Funding Status:
Seed
Headquarters:
Cambridge, Cambridgeshire, United Kingdom